RxDoctor Payments Data

Thao Manh

Physician Assistant · Sacramento, CANPI 1023687548

Payments from drug & device makers

$3,879in general payments, 2019–2025

Across 199 payments — averaging $19.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$418
  • AbbVie$418
  • GSK$401
  • Pfizer$302
  • Johnson & Johnson$267
  • Novo Nordisk$254
  • plus $2K from 34 others

What the payments were for

  • Food & beverage$3,879100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,879 in reported general payments places this provider in the 90th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide17$22,677
JanuviaSitagliptin Phosphate12$15,284
EliquisApixaban22$15,111
BelsomraSuvorexant16$6,887
Albuterol Sulfate HfaAlbuterol Sulfate63$2,271
Atorvastatin Calcium130$1,672
SynthroidLevothyroxine Sodium24$1,669
Rosuvastatin Calcium58$1,101
Levothyroxine Sodium81$985
Metoprolol Succinate57$854
Amlodipine Besylate114$825
Lisinopril90$790
Omeprazole49$743
Valsartan20$635
Tamsulosin Hcl37$619

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$254$22,67717 claims
MerckJanuvia, Belsomra$99$22,17128 claims
PfizerEliquis$302$15,11122 claims
AbbVieSynthroid$418$1,66924 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Sacramento

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →